Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: surgery

April 8, 2026 CD as API / Pharma applications

Sugammadex vs Neostigmine for Reversal of Neuromuscular Blockade and Association with Postoperative Atelectasis After Video-Assisted Thoracoscopic Surgery: A Propensity Score-Matched Cohort Study

Atelectasis means a collapse of the whole lung or an area of the lung. It’s one of the most common breathing

Continue reading

February 14, 2024 Non-pharma applications / Other industrial use / Pharma applications

Cyclodextrin-enabled ultra-strong underwater adhesive

Underwater adhesives have great potential applications in biomedical fields. However, it is challenging to realize underwater adhesion due to screening

Continue reading

two person doing surgery inside room
July 12, 2023 CD derivatives / Diagnosis / Life sciences / Pharma applications

Indocyanine / β-cyclodextrin conjugate enabling imaging of carcinoma tissues upon surgery

Mie University and Nagoya University has jointly developed an Indocyanine / β-cyclodextrin conjugate suitable for ureter visualization in patients undergoing laparoscopic/minimally

Continue reading

June 15, 2022 CD as API / Pharma applications / Uncategorized

Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis

Background: A recent survey revealed that extensive off-label use of sugammadex in pediatric anesthesia deserved particular attention. The present study

Continue reading

Recent Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • New Hungarian Medicine on the Horizon?

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (832)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,241)
  • Supramolecular systems (45)
  • Uncategorized (175)

Top Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • New Hungarian Medicine on the Horizon?
  • Chapter 3: Professor Casu and Cyclodextrins
  • Novel medicament comprising fosaprepitant/SBECD has been approved.
  • Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19
  • New book on beta-cyclodextrin and its derivatives
  • A Novel In Situ Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis
  • Wound dressing based on PVP/PVA nanofibers containing β-cyclodextrin/curcumin complex
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Book chapter: Functionalized cyclodextrins in drug delivery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...